Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BioTime, Inc. (OTCBB: BTIM), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that its common...
BioTime, Inc. (OTCBB:BTIM) announced today that Dr. David Jin, Chief Medical Officer of BioTime’s subsidiary OncoCyte Corporation, will present the keynote address at the Fifth...
BioTime, Inc. (OTCBB:BTIM) announced today that it has organized a new subsidiary, OncoCyte Corporation, for the purpose of developing novel therapeutics for the treatment of...
BioTime, Inc. (OTCBB:BTIM), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that Dr. Michael...
BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem...
BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. will deliver the keynote presentation on Tuesday, September 22, 2009 at the China-USA Scientific Forum of...
BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. will deliver a presentation on Wednesday, September 23, 2009 at the 2009 World Stem Cell Summit meeting in...
BioTime, Inc. (OTCBB: BTIM) announced today that it has completed an Exchange Offer to the holders of notes issued under its revolving line of credit agreement. BioTime issued...
BioTime, Inc. (OTCBB: BTIM) announced today that it had appointed Pedro Lichtinger to its board of directors. Pedro Lichtinger, 55, served as an executive of Pfizer, Inc...
BioTime, Inc. (OTCBB:BTIM) announced today that Walter Funk, Ph.D. has joined its management team as Vice President for Stem Cell Research. Dr. Funk will participate in the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0002 | 0.0002 | 0.0002 | 23750 | 0.0002 | CS |
| 4 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 15573 | 0.00010826 | CS |
| 12 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 23137 | 0.00010389 | CS |
| 26 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 15744 | 0.00010306 | CS |
| 52 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 13331 | 0.00010016 | CS |
| 156 | -0.198 | -99.8990918264 | 0.1982 | 0.35 | 1.0E-6 | 15329 | 0.1361834 | CS |
| 260 | -1.0498 | -99.980952381 | 1.05 | 1.66 | 1.0E-6 | 26445 | 0.62394764 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
